$NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NAVIDEA BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NAVIDEA BIOPHARMACEUTICALS, INC. for free.

CIK Number: 0000810509
IRS Number: 311080091
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NAVB
Company Address: 4995 BRADENTON AVENUE SUITE 240 DUBLIN 43017
Phone number: 6147937500
Former name: NEOPROBE CORP, date of change: 1994-07-14

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Market Capitalization: $77.59M
Prev close: $0.52
Average Daily Volume: 833,077
Days Low: $0.49
Year Low: $0.26
Year High: $1.51

NAVIDEA BIOPHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 21 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.754,000,0003,000,0005,113,0781.1 M to 5.1 M (+359.36 %)
Jun 21 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.754,000,0003,000,0005,113,0781.1 M to 5.1 M (+359.36 %)
Jun 07 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.261,0001,25812,95012 K to 13 K (+8.37 %)
May 21 2019NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorBuyP1.463,3504,9048,3505 K to 8.4 K (+67.00 %)
May 17 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.461,0001,46311,95011 K to 12 K (+9.13 %)
May 17 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.451,5002,18010,9509.5 K to 11 K (+15.87 %)
May 15 2019NAVBNAVIDEA BIOPHARMAC ...Bruck ClaudineDirectorBuyP1.902,5504,8557,5505 K to 7.6 K (+51.00 %)
May 15 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.451,0001,4489,4508.5 K to 9.5 K (+11.83 %)
May 15 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.842,0003,6798,4506.5 K to 8.5 K (+31.01 %)
May 15 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.912,4004,5956,4504.1 K to 6.5 K (+59.26 %)
Mar 25 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.14357,14350,00022,261,56521.9 M to 22.3 M (+1.63 %)
Feb 12 2019NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorOption ExerciseA0.2550,00012,500150,000
Feb 12 2019NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGrantA0.0050,00050150,000100 K to 150 K (+50.00 %)
Feb 12 2019NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorOption ExerciseA0.2550,00012,500100,000
Feb 12 2019NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorGrantA0.0050,00050100,00050 K to 100 K (+100.00 %)

View all NAVIDEA BIOPHARMACEUTICALS, INC. insider transactions.